Skip to main content
Equibles

Yid Mukherjee

Analyst

BTIG

Equibles does not estimate personal net worth.

About Yid Mukherjee

Yid Mukherjee is recorded as Analyst at BTIG. Yid Mukherjee has spoken on 4 earnings calls across 2 companies, most recently for Innate Pharma SA on May 13, 2026. Those appearances were for Innate Pharma SA (IPHA) and INNATE PHARMA. The companies whose calls Yid Mukherjee spoke on are classified in the Healthcare sector.

Yid Mukherjee on recent calls

“Just any further color perspective on the status of the Likudamab partnership discussions? Do you anticipate or feel confident that a deal can be finalized before the third quarter of this year?”
Analyst — BTIG, Earnings conference call (announced in 6-K) ·
“Just any further color perspective on the status of the Likudamab partnership discussions? Do you anticipate or feel confident that a deal can be finalized before the third quarter of this year?”
Analyst — BTIG, INNATE PHARMA Q1 FY2026 Earnings Call ·
“Maybe just starting with Lacutamab, just any color or updates you can share in terms of how those partnership discussions are going? And are there any particular, you know, deal structures or outcomes that you feel best aligns with innate pharma?”
Analyst — BTIG, Innate Pharma SA Q1 FY2026 Earnings Call ·
“Maybe just starting with Lacunab, just any color or updates you can share in terms of how those partnership discussions are going, and are there any particular, you know, deal structures or outcomes that you feel best aligns with innate pharma?”
Analyst — BTIG, INNATE PHARMA Q4 FY2025 Earnings Call ·

Affiliation history

  • BTIG

    Analyst

    Transcript header (unverified)

    Current

Company network

INNATE PHARMA

Biotechnology · Healthcare

2 appearances Latest appearance 2026-05-13

Recent activity